newsfilter
← Latest News
GlobeNewswire·

Christopher Graybill Joins ARCA as Vice President, Clinical Development

WESTMINSTER, Colo., May 05, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (NASDAQ:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced that C